Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.

Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.

Item
http://www.wikidata.org/entity/Q34159900
Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivityEnhancement of cisplatin sensitivity in Lewis Lung carcinoma by liposome-mediated delivery of a survivin mutant.Nanoformulated cell-penetrating survivin mutant and its dual actions.Significance of effector protease receptor-1 expression and its relationship with proliferation and apoptotic index in patients with primary advanced gastric adenocarcinoma.Change in Expression of Survivin Caused by Using Oxaliplatin in HCT116 Colon Cancer CellsConstitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.Enhancement of 5-fluorouracil-induced in vitro and in vivo radiosensitization with MEK inhibition.Survivin, versatile modulation of cell division and apoptosis in cancer.Survivin expression in tuberous sclerosis complex cells.Survivin expression induced by doxorubicin in cholangiocarcinoma.Recent Advances on Small-Molecule Survivin Inhibitors.Non-coding RNAs in the development and pathogenesis of eukaryotic microbes.Survivin as a preferential target for cancer therapy.Oestrogen receptor α mediates 17β-estradiol enhancement of ovarian cancer cell motility through up-regulation of survivin expression.Regulation of survivin expression through Bcr-Abl/MAPK cascade: targeting survivin overcomes imatinib resistance and increases imatinib sensitivity in imatinib-responsive CML cells.Evaluation of tumor-specific promoter activities in melanoma.Transcriptional targeting of tumors with a novel tumor-specific survivin promoter.
P2860

Downregulation of survivin expression by induction of the effector cell protease receptor-1 reduces tumor growth potential and results in an increased sensitivity to anticancer agents in human colon cancer.

Item
http://www.wikidata.org/entity/Q34159900
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Downregulation of survivin exp ...... agents in human colon cancer.
@ast
Downregulation of survivin exp ...... agents in human colon cancer.
@en
Downregulation of survivin exp ...... agents in human colon cancer.
@nl
type
label
Downregulation of survivin exp ...... agents in human colon cancer.
@ast
Downregulation of survivin exp ...... agents in human colon cancer.
@en
Downregulation of survivin exp ...... agents in human colon cancer.
@nl
prefLabel
Downregulation of survivin exp ...... agents in human colon cancer.
@ast
Downregulation of survivin exp ...... agents in human colon cancer.
@en
Downregulation of survivin exp ...... agents in human colon cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Downregulation of survivin exp ...... agents in human colon cancer.
@en
P2093
P304
P31
P356
10.1016/S0959-8049(02)00247-2
P433
P478
P577
P698